Newron Pharmaceuticals to participate in H.C. Wainwright 28th Annual Global Investment Conference, Milan, Italy and Morristown, NJ, USA; CEO presentation, one-on-one meetings
Newron Pharmaceuticals to participate in H.C. Wainwright 28th Annual Global Investment Conference, Milan, Italy and Morristown, NJ, USA; CEO presentation, one-on-one meetings Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference | Newron Pharmaceuticals Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference Milan, Italy, and Morristown, NJ, USA, September 3, 2026 , – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that Stefan Weber , Chief Executive Officer, will participate in the H.C. Wainwright 28 th Annual Global Investment Conference: ...